Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - March 12, 2026 7 Post Content RELATED ARTICLESMORE FROM AUTHOR Josh Lipson, PhD & Roman Palitsky, MDiv, PhD: Psychedelic Harms and the Post-Psychedelic Challenges Study Why Perimenopause Belongs in Psychedelic Research The Psychedelic Practitioner Issue 6: Preparedness (People)
